Update on HIV and SARS-CoV-2: Hybrid Symposium
PART 4 Immune Strategies for COVID19

PART 4 Immune Strategies for COVID19

September 22, 2021

Current status on HIV-1 Cure Clinical Trials 

Update on HIV and SARS-CoV-2 Online Symposium

Prof Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium

 

 

Part 3 Unmasking THE HIV VIRAL RESERVOIR

Part 3 Unmasking THE HIV VIRAL RESERVOIR

August 24, 2021

Distinct viral reservoirs in individuals with spontaneous control of HIV-1

Mathias Lichterfeld, Harvard Medical School, Boston, US

 

How to link clonal proliferation, intact viral sequences and HIV-1 viral rebound

Basiel Col, Ghent University, Ghent, Belgium

 

Implementing HIV-1 intact proviral assays in clinical trials and clinical practice

Robert Siliciano, Johns Hopkins University, Maryland, US

Part 1 COVID Hot Topics

Part 1 COVID Hot Topics

June 22, 2021

A comparison of the two modern pandemics

Prof Nathan Clumeck, Saint-Pierre University Hospital-ULB , Brussels, Belgium

 

COVID-19, ongoing and future therapeutic developments

Prof Bart Lambrecht, Ghent University, Ghent, Belgium

 

 

Part 2 COVID19 Therapeutic Approaches and Societal Impact

Part 2 COVID19 Therapeutic Approaches and Societal Impact

June 22, 2021

Nanobodies to treat SARSCoV2 moving towards clinical trials

Prof Xavier Staelens, Group Leader at the VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium

 

Balance between COVID19 diseases and societal impact

Prof Lieven Annemans, Ghent University and Brussels University (VUB), Ghent, Belgium

 

Podbean App

Play this podcast on Podbean App